Overview
Fumiaki Tokioka practices in Kurashiki, Japan. Tokioka is rated as an Experienced expert by MediFind in the treatment of Rheumatoid Lung Disease. Their top areas of expertise are Pneumonia, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Simple Pulmonary Eosinophilia.
Their clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Rheumatoid Lung Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Interstitial Pneumonia
- Chronic Eosinophilic Pneumonia
- Eosinophilic PneumoniaTokioka isAdvanced. Learn about Eosinophilic Pneumonia.
- Hypereosinophilic SyndromeTokioka isAdvanced. Learn about Hypereosinophilic Syndrome.
- Interstitial Lung DiseaseTokioka isAdvanced. Learn about Interstitial Lung Disease.
- PneumoniaTokioka isAdvanced. Learn about Pneumonia.
- Experienced
- Acute Eosinophilic PneumoniaTokioka isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Bronchiolitis ObliteransTokioka isExperienced. Learn about Bronchiolitis Obliterans.
- DermatomyositisTokioka isExperienced. Learn about Dermatomyositis.
- Hypersensitivity PneumonitisTokioka isExperienced. Learn about Hypersensitivity Pneumonitis.
- Idiopathic Pulmonary FibrosisTokioka isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)